Concepedia
Statistics
Publications
24
Citations
1.7K
H-Index
19
Active since
2017
Affiliations
Augusta University(Current)
Charlie Norwood VA Medical Center
National Cancer Center of Georgia
Augusta University Health
Boston University
John D. Klement is an author at Augusta University specializing in oncology, immunology, and medicine.
Publications per year
2017–2023
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
John D. Klement, Amy V. Paschall, Priscilla S. Redd et al. · Journal of Clinical Investigation · 2018 · 373 citations · Full text
Life Sciences, Immunology, Oncology +17
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
Chunwan Lu, John D. Klement, Mohammed L. Ibrahim et al. · Journal for ImmunoTherapy of Cancer · 2019 · 143 citations · Full text
Medicine, Immunology, Oncology +13
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
Mohammed L. Ibrahim, John D. Klement, Chunwan Lu et al. · Cell Reports · 2018 · 130 citations · Full text
Medicine, Immunology, Oncology +17
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
Huabin Zhu, John D. Klement, Chunwan Lu et al. · The Journal of Immunology · 2021 · 120 citations · Full text
Medicine, Cancer Biology, Oncology +16
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment
John D. Klement, Priscilla S. Redd, Chunwan Lu et al. · Cancer Cell · 2023 · 119 citations · Full text
1–5 of 24